DK0863880T3 - Nye, anti-konvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som indeholder en disubstitueret aminrest i 4-stilling, og fremgangsmåde til deres fremstilling - Google Patents

Nye, anti-konvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som indeholder en disubstitueret aminrest i 4-stilling, og fremgangsmåde til deres fremstilling

Info

Publication number
DK0863880T3
DK0863880T3 DK96927607T DK96927607T DK0863880T3 DK 0863880 T3 DK0863880 T3 DK 0863880T3 DK 96927607 T DK96927607 T DK 96927607T DK 96927607 T DK96927607 T DK 96927607T DK 0863880 T3 DK0863880 T3 DK 0863880T3
Authority
DK
Denmark
Prior art keywords
convulsant
imidazolin
alk
acting
preparation
Prior art date
Application number
DK96927607T
Other languages
English (en)
Inventor
Manfred Menzer
Karl Gewald
Harry Schaefer
Hans-Joachim Lankau
Klaus Unverferth
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0863880(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elbion Ag filed Critical Elbion Ag
Application granted granted Critical
Publication of DK0863880T3 publication Critical patent/DK0863880T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK96927607T 1995-09-05 1996-07-26 Nye, anti-konvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som indeholder en disubstitueret aminrest i 4-stilling, og fremgangsmåde til deres fremstilling DK0863880T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (de) 1995-09-05 1995-09-05 Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
PCT/EP1996/003295 WO1997009314A1 (de) 1995-09-05 1996-07-26 Neue, antikonvulsiv wirkende 1-ar(alk)yl-imidazolin-2-one, die in 4-stellung einen disubstituierten amin-rest enthalten, und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
DK0863880T3 true DK0863880T3 (da) 2004-03-22

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96927607T DK0863880T3 (da) 1995-09-05 1996-07-26 Nye, anti-konvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som indeholder en disubstitueret aminrest i 4-stilling, og fremgangsmåde til deres fremstilling

Country Status (32)

Country Link
EP (1) EP0863880B1 (da)
JP (1) JP4030578B2 (da)
CN (1) CN1103762C (da)
AR (1) AR003502A1 (da)
AT (1) ATE254606T1 (da)
AU (1) AU700602B2 (da)
BG (1) BG63917B1 (da)
BR (1) BR9610359A (da)
CA (1) CA2184871C (da)
CZ (1) CZ291839B6 (da)
DE (2) DE19532668A1 (da)
DK (1) DK0863880T3 (da)
EA (1) EA000535B1 (da)
EE (1) EE03562B1 (da)
ES (1) ES2208758T3 (da)
FR (1) FR13C0049I2 (da)
GE (1) GEP20022652B (da)
HK (1) HK1015776A1 (da)
HU (1) HU225956B1 (da)
IL (1) IL123333A (da)
LT (1) LT4482B (da)
LU (1) LU92263I2 (da)
NO (1) NO313829B1 (da)
NZ (1) NZ315624A (da)
PL (1) PL188287B1 (da)
PT (1) PT863880E (da)
SK (1) SK284868B6 (da)
TR (1) TR199800476T1 (da)
TW (1) TW422838B (da)
UA (1) UA46790C2 (da)
WO (1) WO1997009314A1 (da)
ZA (1) ZA967014B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (de) * 1997-05-23 1998-11-26 Dresden Arzneimittel Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
CN101254189A (zh) * 2003-07-11 2008-09-03 埃尔比昂股份公司 用对苯并二氮杂䓬受体的α3亚基具有选择性的化合物治疗或预防中枢神经系统病症的方法
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
BR112014003117A2 (pt) 2011-08-12 2017-06-13 Boehringer Ingelheim Vetmedica Gmbh inibidores da corrente funny (if) para uso em um método de tratamento e prevenção de insuficiência cardíaca em felino
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (fr) 1971-10-21 1973-04-20 American Cyanamid Co Nouvelles (p-chloro) phenyl-1 methyl-3 imidazolidines, 2,4-disubstituees utiles notamment comme agents diuretiques antialdosterone et leur procede de preparation
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
BG102287A (en) 1998-09-30
NO980906L (no) 1998-03-02
NO980906D0 (no) 1998-03-02
EP0863880A1 (de) 1998-09-16
LT4482B (lt) 1999-03-25
JP4030578B2 (ja) 2008-01-09
HK1015776A1 (en) 1999-10-22
HUP9802941A3 (en) 1999-10-28
EE9800063A (et) 1998-08-17
FR13C0049I2 (fr) 2014-03-28
ATE254606T1 (de) 2003-12-15
FR13C0049I1 (da) 2013-09-27
DE59610827D1 (de) 2003-12-24
BR9610359A (pt) 1999-07-06
MX9801742A (es) 1998-08-30
NO313829B1 (no) 2002-12-09
JPH11512101A (ja) 1999-10-19
DE19532668A1 (de) 1997-03-06
CN1103762C (zh) 2003-03-26
PL325413A1 (en) 1998-07-20
EA199800271A1 (ru) 1998-10-29
LT98047A (en) 1998-10-26
HU225956B1 (en) 2008-01-28
HUP9802941A2 (hu) 1999-09-28
GEP20022652B (en) 2002-03-25
UA46790C2 (uk) 2002-06-17
CZ291839B6 (cs) 2003-06-18
AR003502A1 (es) 1998-08-05
CN1200728A (zh) 1998-12-02
SK284868B6 (sk) 2006-01-05
LU92263I2 (fr) 2013-10-07
AU6737596A (en) 1997-03-27
TR199800476T1 (xx) 1998-06-22
BG63917B1 (bg) 2003-06-30
SK21698A3 (en) 1998-10-07
EP0863880B1 (de) 2003-11-19
EE03562B1 (et) 2001-12-17
WO1997009314A1 (de) 1997-03-13
CA2184871C (en) 2001-08-21
IL123333A0 (en) 1998-09-24
ES2208758T3 (es) 2004-06-16
NZ315624A (en) 1998-11-25
IL123333A (en) 2001-10-31
TW422838B (en) 2001-02-21
EA000535B1 (ru) 1999-10-28
PL188287B1 (pl) 2005-01-31
CZ66198A3 (cs) 1998-07-15
AU700602B2 (en) 1999-01-07
CA2184871A1 (en) 1997-03-06
PT863880E (pt) 2004-04-30
ZA967014B (en) 1997-08-18

Similar Documents

Publication Publication Date Title
DK0855999T3 (da) 1-(1,2-disubstituerede piperidinyl)-4-substituerede piperidinderivater som tachykininreceptorantagonister
NO981534D0 (no) 1-(1,2-disubstituert piperidinyl)-4-substituerte piperazinderivater
NO20005454D0 (no) Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmÕte for fremstilling derav
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
DK0736130T3 (da) Fremgangsmåde til at hindre, at gashydrater tilpropper ledninger
DK0676409T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ATE201872T1 (de) Kristallines hydrochlorid von (r)-(-)-2-(n-(4-(1, 1-dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl) butyl)-aminomethyl)-chroman
NO964654L (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DK321989A (da) Trykkapsel til en spraydaase samt en spraydaase, som anvender en saadan kapsel
DK641589D0 (da) N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer
DK0858440T3 (da) Fremgangsmåde til fremstilling af 1,1,1,3,3-pentafluorpropan
DK0843679T3 (da) 1-(1,2-disubstitueret piperidinyl)-4-(kondenseret midazol)-piperidinderivater
DK1045856T3 (da) Nye aromatiske amider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO985671L (no) Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte
AR004368A1 (es) Compuestos de piperidina -1,-4 sustituida, procedimientos para prepararlos y un procedimiento para preparar 1-bencil-4-((5,6-dimetoxi-1-indanon)-2-il)metilpiperidina mediante dichos compuestos.
DK0863880T3 (da) Nye, anti-konvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som indeholder en disubstitueret aminrest i 4-stilling, og fremgangsmåde til deres fremstilling
NO304828B1 (no) Nye cykliske aminosyrer og derivater derav, fremgangsmÕte til deres fremstilling samt mellomprodukt
DK0838469T3 (da) 10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser
NO944680D0 (no) Nye tienotiazinerivater, en fremgangsmåte til fremstilling derav samt deres anvendelse
DK0946579T3 (da) Nye forbindelser afledt af erythromcin, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ITVI910109A1 (it) Regolatore di pressione per gas.
NO20000199D0 (no) Medikamenter inneholdende polyhydroksybutylpyraziner, nye polyhydroksybutylpyraziner og deres fremstilling
DK0452850T3 (da) 4-[3-(Oxothiazoldinyl)]butynylaminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO980309D0 (no) Nye, anti-konvulsive imidazolin-2,4-dioner med en ortosubstituert ar(alk)yl-rest i 1-stilling, og deres fremstilling
DK1293506T3 (da) Nye 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazin forbindelser, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser